This text is a result of machine translation.
Anjoy Foods Q3 Net Profit Totaled CNY 386 million, with an Impressive YoY Increase of 63.75%
Survival Rules for Turbulent Times: A Compilation of the 20 Most Unmissable Core Insights from the 2026 Tsinghua PBCSF Forum
A dialogue between Zhu Min, former Deputy Governor of the People's Bank of China and former Vice Managing Director of the International Monetary Fund; Michael Spence, 2001 Nobel Prize winner in Economics and Philip H. Knight Professor Emeritus of Management at Stanford Graduate School of Business; and Masaaki Shirakawa, former Governor of the Bank of Japan, at the 2026 Tsinghua PBCSF Global Finance Forum.
May 18, 2026 02:22 PM
China's Outbound Non-financial Direct Investment Increased 18.8% YoY
Electric Vehicles to Account for Two-thirds of Global Vehicle Sales by 2030
New Energy Vehicle Sales Up 27% in August 2023
Tesla Announces Global Supercharger Network Surpasses 50,000 Units
Unpacking China | Key Chinese Firms to Watch This Week (26/07/2026-01/08/2026)
Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.
Updated 13 hours ago
Mabwell Signs GCC Licensing Deal with Saudi Arabia’s SVAX for Aflibercept Biosimilar
Mabwell (Shanghai) Bioscience Co., Ltd.(迈威(上海)生物科技股份有限公司)has entered into a licensing agreement with Saudi Arabian biopharmaceutical company SVAX Inc. covering its aflibercept biosimilar, 9MW0813, in the Gulf Cooperation Council market.
Yesterday 03:00 PM
We-Linking Raised Over CNY 10 Mn in Angel Round
Intraoperative Neurophysiological Monitoring Equipment Developer NeuroFlag Closed An Angel Round
Innovative Drug Developer Rezu Bio Raised CNY 10 Mn in Series Pre-A
CFMOTO’s Overseas Revenue More Than Quintuples in Five Years, Reaching 70% of 2025 Sales
Zhejiang CFMOTO Power Co., Ltd.(浙江春风动力股份有限公司), the Hangzhou-based powersports manufacturer behind the CFMOTO brand, generated CNY 13.79 billion in overseas revenue in 2025, accounting for 69.8% of its total sales. The figure was up 27.6% from a year earlier and more than five times the CNY 2.555 billion the company recorded in overseas sales in 2020.
Yesterday 02:27 PM
CTTQ, Ampsourcebio Ink Agreement on Cure for NASH, T2DM
There are more than 95 plus major players and more than 90 plus nonalcoholic steatohepatitis (NASH) pipeline therapies, but none of them has been approved for marketing. Who would survive the competition in the blue-ocean market for NASH?
Apr 27, 2022 09:45 PM
China biopharmaceutical: the fifth indication of anti-tumor drug "arotinib hydrochloride capsule" has been approved
China biopharmaceutical: second generation highly selective P2X3 inhibitor approved clinical trial
Jin Litai: the prices of various types of cathodic electrophoretic paint products rise by 10% - 20%
A Small Aircraft, a Bigger Bet: How China's Worthy Aero Plans to Scale Up
Yesterday 02:44 PM
EqualOcean Releases 2026 Chinese GoGlobal Physical Retail Brands Top 10 at GGF2026
Jun 17, 2026 02:50 PM